Research Topic · Peer-Reviewed

Metabolic Disorders

Metabolic disorders are diseases in which normal biochemical processes are disrupted, impairing the production, use, or storage of energy and the handling of carbohydrates, lipids, proteins, and other metabolites. They include inherited inborn errors of metabolism caused by enzyme deficiencies and acquired condition…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 25× across the literature 🔖 ISSN 2578-2371 🗓 Reviewed July 2026

Overview

Metabolic disorders are diseases in which normal biochemical processes are disrupted, impairing the production, use, or storage of energy and the handling of carbohydrates, lipids, proteins, and other metabolites. They include inherited inborn errors of metabolism caused by enzyme deficiencies and acquired conditions such as diabetes, dyslipidaemia, hyperuricaemia, and metabolic syndrome that arise from the interaction of genetic predisposition with diet, lifestyle, and environmental exposure. Their consequences range from energy imbalance and weight change to organ dysfunction, particularly of the liver, which is central to metabolic homeostasis, and management spans dietary modification, lifestyle change, and pharmacotherapy. The peer-reviewed work assembled here engages these themes within Spleen And Liver Research: the pathogenesis of familial combined hyperlipidaemia and its association with metabolic syndrome, the magnitude and trends of chronic liver disease, amino acids in liver-disease pathogenesis and treatment, interventions to reduce cardio-metabolic risk, hyperuricaemia management, hepatic metabolomic responses to toxicity, dietary approaches to reversing obesity, and cardiometabolic phenotypes linked to early-life factors. Across these studies metabolic disorders appear through lipid and uric-acid abnormalities, hepatic metabolic disease, and the cardio-metabolic risk cluster, with attention to genetic, dietary, and lifestyle contributions. The collection situates metabolic disorders as a broad category of energy- and substrate-handling disease in which the liver and systemic metabolism are central.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 12 articles above have been cited 25 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Metabolic Disorders, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Spleen And Liver Research (ISSN 2578-2371).

Journal editorial board
Florin Graur · Romania

This page summarises published research for orientation; it is not medical or professional advice.